NDC 62135-520-05 - Oxybutynin Chloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 62135-520
- Requested NDC
- 62135-520-05
- Package NDCs from labels
- 62135-520-47, 62135-520-05, 62135-520-24
- Manufacturer
- Chartwell RX, LLC
- Effective date
- 2025-02-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Oxybutynin Chloride - Chartwell RX, LLC | Chartwell RX, LLC | 2025-02-26 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62135-520-05 | Oxybutynin Chloride | 5 mL in 1 CUP | SOLUTION | 5 | 2 | |
| 62135-520-24 | Oxybutynin Chloride | 2 in 1 BOX | SOLUTION | 2 | 2 | |
| 62135-520-24 | Oxybutynin Chloride | 10 in 1 TRAY | SOLUTION | 10 | 2 | |
| 62135-520-47 | Oxybutynin Chloride | 473 mL in 1 BOTTLE | SOLUTION | 473 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 62135-520-05 | ML - Milliliter | 62135-520 | e2171b21-8cc7-42cc-b3b1-91b7e0a7f954 | 1 | 2025-05-14 |
| 62135-520-24 | ML - Milliliter | 62135-520 | 5df0034f-a3cc-4d28-9435-ae14c1181857 | 1 | 2025-05-14 |
| 62135-520-47 | ML - Milliliter | 62135-520 | e8f5f306-8d83-45c2-b683-a4d520825ca2 | 1 | 2023-02-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | REMEDYREPACK INC. | 1a08a16a-f16d-4ef1-95bb-6943bcae0737 | 2026-07-28 | Warnings, Adverse reactions | L9F3D9RENQ |
| Topwin Speedy Enema | GLYCERIN | Health Chemical Pharmaceutical Co., Ltd | 3ba8c3d2-1780-42e1-bec5-8f98771d475e | 2026-07-27 | Warnings | PDC6A3C0OX |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | TruPharma LLC | 7c497c6c-2448-2c80-e053-2991aa0ab8c7 | 2026-07-27 | Warnings, Adverse reactions | L9F3D9RENQ |
| Neutraflush | EYEWASH STATION ADDITIVE CONCENTRATE | Aero Healthcare | 1d9ff2ef-9c9b-f367-e063-6294a90afa0e | 2026-07-24 | Warnings | 6DC9Q167V3 |
| Droptics Dry Eye Relief | CARBOXYMETHYLCELLULOSE SODIUM,GLYCERIN,POLYSORBATE 80 | Droptics LLC | 29d7614b-f4b7-48e2-97c5-d1bff27731d2 | 2026-07-22 | Warnings | PDC6A3C0OX |
| Xenleta | LEFAMULIN ACETATE | Meitheal Pharmaceuticals Inc. | eb972ea8-7502-422e-84bb-66cb8e93ca06 | 2026-07-22 | Warnings, Adverse reactions | XF417D3PSL |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | RISING PHARMA HOLDINGS, INC. | 9578b6b8-5b9d-4263-9142-39b2c7216b85 | 2026-07-21 | Warnings, Adverse reactions | L9F3D9RENQ |
| FUNGAL NAIL TREATMENT kit .cream. | PSEUDOLARIX AMABILIS BARK 1% | GETHSEMANE BRANCH CORPORATION | 56c9d9fa-09ad-e26a-e063-6394a90a0ed9 | 2026-07-17 | Warnings | 6DC9Q167V3 |
| Eyewash Station Additive Concentrate | CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL | Global Equipment Company | bc93a1e8-aa3c-6735-e053-2995a90ad6e8 | 2026-07-16 | Warnings | 6DC9Q167V3 |
| Revitalize Energizing Eye Drops | NAPHAZOLINE HYDROCHLORIDE ,PROPYLENE GLYCOL | Revitalize Energy Inc. | 518aac87-1642-4b2f-bca1-b74d21261eea | 2026-07-16 | Warnings | 6DC9Q167V3 |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | ATLANTIC BIOLOGICALS CORP. | fe4ed76b-0009-455f-be30-47e80fc1afdf | 2026-07-09 | Warnings, Adverse reactions | 863599 L9F3D9RENQ |
| Freskaro Ear Drops for Swimmers | FRESKARO EAR DROPS FOR SWIMMERS | Pharma Nobis, LLC | 4f724d85-cd38-41da-e063-6394a90a9fd7 | 2026-07-08 | Warnings | PDC6A3C0OX |
| Artificial Tears | ARTIFICIAL TEARS | AvPAK | f18bebf2-1936-658f-e053-2a95a90a5012 | 2026-07-07 | Warnings | PDC6A3C0OX |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Coupler LLC | 55f618d1-4463-3200-e063-6394a90a89a8 | 2026-07-06 | Warnings, Adverse reactions | L9F3D9RENQ |
| Dr. Drop NMN Vital Balance (Drop No.1 Cream 90g) | NMN (NICOTINAMIDE MONONUCLEOTIDE), ECTOIN (ECTOINE) | Reedfresh Co., LTD | 55d703ca-ff9d-0dbc-e063-6294a90ab6b1 | 2026-07-05 | Warnings | PDC6A3C0OX |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Strides Pharma Science Limited | 9ede5def-d185-4e40-9c10-8663ac654caf | 2026-07-01 | Warnings, Adverse reactions | L9F3D9RENQ |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 552d9018-cc7d-7e1a-e063-6294a90a3322 | 2026-06-26 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 552e16b9-f46a-7838-e063-6394a90ab8aa | 2026-06-26 | Warnings | PDC6A3C0OX |
| Chemstat | GLYCERINUM, TARAXACUM OFFICINALE, PHYTOLACCA DECANDRA, ARSENICUM ALBUM, BOVISTA, CARBO VEGETABILIS, CARBONEUM SULPHURATUM, COFFEA CRUDA, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, SULPHUR, ACETYLSALICYLICUM ACIDUM, FORMALINUM, GLONOINUM, INSULINUM (HUMAN), LITHIUM CARBONICUM, TEREBINTHINA, THYROIDINUM (SUIS), ACETICUM ACIDUM, BENZOICUM ACIDUM, BENZYL ALCOHOL, BORICUM ACIDUM, CHLORINUM, CORTISONE ACETICUM, EUGENOL, FOLLICULINUM, ISOPROPYL PALMITATE, LACTICUM ACIDUM, | Energique, Inc. | 2e361b50-9268-4053-b13c-93af64549848 | 2026-06-25 | Warnings | PDC6A3C0OX 506T60A25R |
| SET 4TE HOMO | ADEPS SUILLUS, BRYONIA (ALBA), CALCAREA PHOSPHORICA, CHOLINUM, DNA, DOPAMINE (HYDROCHLORIDE), FERRUM PHOSPHORICUM, FOLIC ACID, INSULINUM (HUMAN), LEPTIN, MAGNESIA MURIATICA, L-METHIONINE, METHYLCOBALAMIN, PROTEUS (VULGARIS), RHUS TOX, RIBOFLAVINUM, RUTA GRAVEOLENS, SACCHARUM OFFICINALE, THIOSINAMINUM, ZINCUM METALLICUM | Deseret Biologicals, Inc. | e7b8d75b-f2bc-4013-91e7-bf5bbec11a90 | 2026-06-25 | Warnings | C151H8M554 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.